Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
NRG Oncology
Institut Cancerologie de l'Ouest